| Language | English |
|---|---|
| Pages | 109-117 |
| Journal | Recent Patents on CNS Drug Discovery |
| Volume | 5 |
| Publication status | Published - 2010 |
Cite this
@article{b924c63dde94482c94ff8553547cf54a,
title = "Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease",
author = "Christian Holscher",
year = "2010",
language = "English",
volume = "5",
pages = "109--117",
journal = "Recent Patents on CNS Drug Discovery",
issn = "1574-8898",
}
Holscher, C 2010, 'Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease', Recent Patents on CNS Drug Discovery, vol. 5, pp. 109-117.
Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease. / Holscher, Christian.
In: Recent Patents on CNS Drug Discovery, Vol. 5, 2010, p. 109-117.Research output: Contribution to journal › Article
TY - JOUR
T1 - Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease
AU - Holscher, Christian
PY - 2010
Y1 - 2010
M3 - Article
VL - 5
SP - 109
EP - 117
JO - Recent Patents on CNS Drug Discovery
T2 - Recent Patents on CNS Drug Discovery
JF - Recent Patents on CNS Drug Discovery
SN - 1574-8898
ER -